已收录 268921 条政策
 政策提纲
  • 暂无提纲
Regulation of fibroblast growth factor 23 (FGF23) in health and disease
[摘要] Fibroblast growth factor 23 (FGF23) is mainly produced in the bone and, upon secretion, forms a complex with a FGF receptor and coreceptor aKlotho. FGF23 can exert several endocrine functions, such as inhibiting renal phosphate reabsorption and 1,25-dihydroxyvitamin D3 production. Moreover, it has paracrine activities on several cell types, including neutrophils and hepatocytes. Klotho and Fgf23 deficiencies result in pathologies otherwise encountered in age-associated diseases, mainly as a result of hyperphosphataemia-dependent calcification. FGF23 levels are also perturbed in the plasma of patients with several disorders, including kidney or cardiovascular diseases. Here, we review mechanisms controlling FGF23 production and discuss how FGF23 regulation is perturbed in disease.
[发布日期]  [发布机构] 
[效力级别]  [学科分类] 
[关键词] FGF23;phosphate;inflammation;Ca2+;Klotho [时效性] 
   浏览次数:3      统一登录查看全文      激活码登录查看全文